ScopeSt George’s University Hospitals NHS Foundation Trust
143 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Division of Infection and Immunity, Department of Medical Microbiology, South West London Pathology, St George’s University Hospital, Blackshaw Road, Tooting
Tooting SW17 0QT , United Kingdom
Tooting SW17 0QT , United Kingdom
Accreditation
Active
UKAS
9810
stgeorges.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
9810
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
St George’s University Hospitals NHS Foundation Trust
Surrey
St George’s University Hospitals NHS Foundation Trust
Cranmer Terrace
St George’s University Hospitals NHS Foundation Trust
Tooting
St George’s University Hospitals NHS Foundation Trust
Tooting
St George’s University Hospitals NHS Foundation Trust
London
Test Capabilities (143)
| Standard Reference | Description | Category |
|---|---|---|
| Toxoplasma IgG | Toxoplasma IgG | Biocompatibility (ISO 10993) |
| Toxoplasma IgM | Toxoplasma IgM | Biocompatibility (ISO 10993) |
| Quantitative detection of : Renin | Quantitative detection of: | Latex agglutination using | Clinical Chemistry |
| Aeromonas sp | Aeromonas sp | Clinical Microbiology |
| Antibiotic sensitivity testing in critical strains, including: Extended-spectrum β-lactamases (ESBL) | Antibiotic sensitivity testing in critical strains, including: Extended-spectrum β-lactamases (ESBL) | Clinical Microbiology |
| Antimicrobial susceptibility testing (AST) | Antimicrobial susceptibility testing (AST) | Clinical Microbiology |
| Antimicrobial susceptibility testing of Neisseria gonorrhoeae | Antimicrobial susceptibility testing of Neisseria gonorrhoeae | Clinical Microbiology |
| Continuous monitoring for blood cultures for the isolation of clinically significant bacteria (positive samples transferred to location SGH) | Continuous monitoring for blood cultures for the isolation of clinically significant bacteria (positive samples transferred to location SGH) | Clinical Microbiology |
| Cryptosporidium parvum/ hominis | Cryptosporidium parvum/ hominis | Clinical Microbiology |
| Culture and detection of microorganisms of clinical significance | Culture and detection of microorganisms of clinical significance | Clinical Microbiology |
| Detection of Clostridioides difficile | Detection of Clostridioides difficile | Clinical Microbiology |
| Detection of Enterobius vermicularis | Detection of Enterobius vermicularis | Clinical Microbiology |
| Detection of MRSA | Detection of MRSA | Clinical Microbiology |
| Detection of Norovirus | Detection of Norovirus | Clinical Microbiology |
| Detection of Ova, Cysts and Parasites | Detection of ova, cysts and parasites | Clinical Microbiology |
| Detection of Pneumococcal soluble antigen | Detection of Pneumococcal soluble antigen | Clinical Microbiology |
| Detection of Schistosoma haematobium ova | Detection of Schistosoma haematobium ova | Clinical Microbiology |
| Detection of VRE/GRE (Glycopeptide Resistant Enterococci) | Detection of VRE/GRE (Glycopeptide Resistant Enterococci) | Clinical Microbiology |
| Differentiation of different organism types: gram positive/negative/variable, branching organisms, yeasts | Differentiation of different organism types: gram positive/negative/variable, branching organisms, yeasts | Clinical Microbiology |
| GDH and toxin | GDH and toxin | Clinical Microbiology |
| GDH antigen | GDH antigen | Clinical Microbiology |
| Gram negative screening | Gram negative screening | Clinical Microbiology |
| Identification of Microorganisms of clinical significance | Identification of microorganisms of clinical significance | Clinical Microbiology |
| Identification of Mycobacterium tuberculosis complex | Identification of Mycobacterium tuberculosis complex | Clinical Microbiology |
| Isolation and characterisation of bacterial and fungal isolates of clinical significance | Isolation and characterisation of bacterial and fungal isolates of clinical significance | Clinical Microbiology |
| Isolation and characterisation of bacterial and yeast isolates of clinical significance | Isolation and characterisation of bacterial and yeast isolates of clinical significance | Clinical Microbiology |
| Isolation and identification of N. gonorrhoeae / N. meningitidis | Isolation and identification of N. gonorrhoeae / N. meningitidis | Clinical Microbiology |
| Isolation and identification of fungi of clinical significance | Isolation and identification of fungi of clinical significance | Clinical Microbiology |
| Isolation and presumptive identification of Mycobacterium species | Isolation and presumptive identification of Mycobacterium species | Clinical Microbiology |
| Isolation of Mycobacterium species | Isolation of Mycobacterium species | Clinical Microbiology |
| Isolation of bacterial and fungal species of clinical significance; direct susceptibility testing and identification tests | Isolation of bacterial and fungal species of clinical significance; direct susceptibility testing and identification tests | Clinical Microbiology |
| Isolation, identification and Antimicrobial Susceptibility of bacterial pathogens including: Campylobacter spp | Isolation, identification and Antimicrobial Susceptibility of bacterial pathogens including: Campylobacter spp | Clinical Microbiology |
| KPC ( Klebsiella pneumoniae carbapenemases) | KPC ( Klebsiella pneumoniae carbapenemases) | Clinical Microbiology |
| Metallo-β-lactamases (MBL) | Metallo-β-lactamases (MBL) | Clinical Microbiology |
| Microbiology examination activities for the purposes of clinical diagnosis | Microbiology examination activities for the purposes of clinical diagnosis | Clinical Microbiology |
| OXA-48 carbapenemases | OXA-48 carbapenemases | Clinical Microbiology |
| Pleisiomonas spp | Pleisiomonas spp | Clinical Microbiology |
| Presence or absence of fungal elements | Presence or absence of fungal elements | Clinical Microbiology |
| Rapid detection and differentiation of the KPC, NDM, VIM, IMP, OXA-48 carbapenemases | Rapid detection and differentiation of the KPC, NDM, VIM, IMP, OXA-48 carbapenemases | Clinical Microbiology |
| Salmonella Sp | Salmonella sp. | Clinical Microbiology |
| Toxin A + B | Toxin A + B | Clinical Microbiology |
| Vibrio spp | Vibrio spp. | Clinical Microbiology |
| Yeast cells and fungal hyphae | Yeast cells and fungal hyphae | Clinical Microbiology |
| Yersinia spp | Yersinia spp | Clinical Microbiology |
| Astrovirus | Astrovirus | Food Safety Testing |
| Enterovirus | Enterovirus | Food Safety Testing |
| Escherichia coli O157 | Escherichia coli O157 | Food Safety Testing |
| Giardia lamblia | Giardia lamblia | Food Safety Testing |
| HSV 2 | HSV-2 | Food Safety Testing |
| Parvovirus B19 IgM | Parvovirus B19-IgM | Food Safety Testing |
| Rubella IgG | Rubella IgG | Food Safety Testing |
| Rubella IgM | Rubella IgM | Food Safety Testing |
| Shigella spp | Shigella spp | Food Safety Testing |
| Adenovirus | Adenovirus | Immunology / Serology |
| Anti-Streptolysin O | Anti-Streptolysin-O | Immunology / Serology |
| CMV IgG | CMV IgG | Immunology / Serology |
| CMV IgM | CMV IgM | Immunology / Serology |
| Confirmation and discrimination of antibodies to HIV-1, HIV-2 group O and HIV-2 HIV 1/2 Ag / Ab antigen/antibody 4 th | Confirmation and discrimination of antibodies to HIV-1, HIV-2 group O and HIV-2 HIV 1/2 Ag / Ab antigen/antibody 4 th | Immunology / Serology |
| Detection of | Detection of : | Manual Indirect | Immunology / Serology |
| EBV IgG (EBNA IgG) | EBV IgG (EBNA IgG) | Immunology / Serology |
| EBV IgG (VCA IgG) | EBV IgG (VCA IgG) | Immunology / Serology |
| EBV IgM (VCA) | EBV IgM (VCA) | Immunology / Serology |
| HIV Ab/Ag | HIV ab/ag | Immunology / Serology |
| HIV Antigen and Antibody 4th gen (reported separately) | HIV Antigen and Antibody 4th gen (reported separately) | Immunology / Serology |
| HSV 1 IgG | HSV 1 IgG | Immunology / Serology |
| HSV 2 IgG | Serum | HSV 2 IgG | Immunology / Serology |
| HTLV 1 + 2 | HTLV 1 + 2 | Immunology / Serology |
| Hep B core IgM | Hep B core IgM | Immunology / Serology |
| Hep B core total Ab | Hep B core total Ab | Immunology / Serology |
| Hep B surface Ag | Hep B surface Ag | Immunology / Serology |
| Hep B surface Ag quantitative | Hep B surface Ag quantitative | Immunology / Serology |
| Hep E IgG | Hep E IgG | Immunology / Serology |
| Hep E IgM | Hep E IgM | Immunology / Serology |
| HepBc IgM | HepBc IgM | Immunology / Serology |
| HepBc total Ab | HepBc total Ab | Immunology / Serology |
| Lyme IgG ( Borrelia burgdorferi) | Lyme IgG ( Borrelia burgdorferi) | Immunology / Serology |
| Lyme IgM ( Borrelia burgdorferi) | Lyme IgM ( Borrelia burgdorferi) | Immunology / Serology |
| Measles IgG Antibody | Measles IgG antibody | Immunology / Serology |
| Mumps IgG Antibody | Mumps IgG antibody | Immunology / Serology |
| Mumps IgM | Mumps IgM | Immunology / Serology |
| Parvovirus B19 IgG | Anti-Parvovirus B19-IgG | Immunology / Serology |
| Qualitative detection of IgG and IgM antibodies to Treponema pallidum | Qualitative detection of IgG and IgM antibodies to Treponema pallidum | Immunology / Serology |
| Serological examination activities for the purposes of clinical diagnosis | Serological examination activities for the purposes of clinical diagnosis: Detection of Bartonella | Immunology / Serology |
| Syphilis | Syphilis | Immunology / Serology |
| Syphilis (treponemal) screen total antibody | Syphilis (treponemal) screen total antibody | Immunology / Serology |
| Treponema pallidum screening for syphilis | Treponema pallidum screening for syphilis | Immunology / Serology |
| VCA IgG | VCA-IgG | Immunology / Serology |
| VZV IgG quantitative | VZV IgG quantitative | Immunology / Serology |
| (Panton-Valentine Leukocidin) from cultures of Staphylococcus aureus | (Panton-Valentine Leukocidin) from cultures of Staphylococcus aureus | Molecular Diagnostics / PCR |
| Chlamydia trachomatis (dual target MOMP/plasmid genes) | Chlamydia trachomatis (dual target MOMP/plasmid genes) | Molecular Diagnostics / PCR |
| Clostridioides difficile test | Clostridioides difficile test | Molecular Diagnostics / PCR |
| Cobas Liat Influenza A/B & RSV assay | Cobas Liat Influenza A/B & RSV assay | Molecular Diagnostics / PCR |
| Detection and quantification of human adenovirus | Detection and quantification of human adenovirus | Molecular Diagnostics / PCR |
| Detection of MRSA (mecA) | Detection of MRSA (mecA) | Molecular Diagnostics / PCR |
| Detection of Mycobacterium genitalium | Detection of Mycobacterium genitalium | Molecular Diagnostics / PCR |
| Detection of N. gonorrhoeae | Detection of N. gonorrhoeae | Molecular Diagnostics / PCR |
| Detection of SARS CoV-2 antigen N2, E and RdRP genes | Detection of SARS CoV-2 antigen N2, E and RdRP genes | Molecular Diagnostics / PCR |
| Detection of SARS-CoV-2 (ORF1a/b and E gene) | Detection of SARS-CoV-2 (ORF1a/b and E gene) | Molecular Diagnostics / PCR |
| Detection of Trichomonas vaginalis and Mycobacterium genitalium | Detection of Trichomonas vaginalis and Mycobacterium genitalium | Molecular Diagnostics / PCR |
| Differential diagnosis of SARS-CoV- 2/FLU/RSV | Differential diagnosis of SARS-CoV- 2/FLU/RSV | Molecular Diagnostics / PCR |
| HSV 1/2 DNA detection | HSV 1/2 DNA detection | Molecular Diagnostics / PCR |
| Meningitis PCR Assay VMPCR | Meningitis PCR Assay VMPCR | Molecular Diagnostics / PCR |
| Molecular examination activities for the purposes of clinical diagnosis | Molecular examination activities for the purposes of clinical diagnosis: Detection of Chlamydia trachomatis and Neisseria gonorrhoea | Molecular Diagnostics / PCR |
| Neisseria gonorrhoeae (dual target- conserved DR9 and sequence variant of N. gonorrhoeae DNA) | Neisseria gonorrhoeae (dual target- conserved DR9 and sequence variant of N. gonorrhoeae DNA) | Molecular Diagnostics / PCR |
| Parechovirus | Parechovirus | Molecular Diagnostics / PCR |
| Qualitative detection of M. tuberculosis complex and the presence/absence of mutations conferring resistance to rifampicin | Qualitative detection of M. tuberculosis complex and the presence/absence of mutations conferring resistance to rifampicin | Molecular Diagnostics / PCR |
| Quantification of HBV DNA (iu/mL) | Quantification of HBV DNA (iu/mL) | Molecular Diagnostics / PCR |
| Quantification of HCV RNA (iu/mL) | Quantification of HCV RNA (iu/mL) | Molecular Diagnostics / PCR |
| Quantification of HIV-1 RNA (copies/mL) | Quantification of HIV-1 RNA (copies/mL) | Molecular Diagnostics / PCR |
| Quantitative detection of BKV | Quantitative detection of BKV | Molecular Diagnostics / PCR |
| Quantitative detection of CMV | Quantitative detection of CMV | Molecular Diagnostics / PCR |
| Quantitative detection of CMV DNA | Quantitative detection of CMV DNA | Molecular Diagnostics / PCR |
| Quantitative detection of EBV DNA | Quantitative detection of EBV DNA | Molecular Diagnostics / PCR |
| RPCR inc. SARS CoV2 | RPCR inc. SARS CoV2 | Molecular Diagnostics / PCR |
| Sapovirus | Sapovirus | Molecular Diagnostics / PCR |
| VZV | VZV | Molecular Diagnostics / PCR |
| Viral meningitis panel: HSV 1 | Viral meningitis panel: HSV 1 | Molecular Diagnostics / PCR |
| Viral skin panel: HSV 1 | Viral skin panel: HSV 1 | Molecular Diagnostics / PCR |
| (OCP) | (OCP) | Other |
| Adenovirus F40/F41 | Adenovirus F40/F41 | Other |
| Automated cell count | Automated cell count | Other |
| Bacterial Cells | Bacterial cells | Other |
| Campylobacter jejuni/coli/lari | Campylobacter jejuni/coli/lari | Other |
| Detection of Legionella pneumophila serogroup 1 antigen | Detection of Legionella pneumophila serogroup 1 antigen | Other |
| Detection, identification and quantification of : Red cells | Detection, identification and quantification of: White blood cells | Other |
| Galactomannan Lateral Flow Assay (LFA) immunochromatographic test system for the qualitative detection of Aspergillus galactomannan | Galactomannan Lateral Flow Assay (LFA) immunochromatographic test system for the qualitative detection of Aspergillus galactomannan | Other |
| HIV DUO Antigen & Antib (VIDAS 4th gen) VZV IgG Hepatitis B core total Hep B surface antigen Anti-HCV Rubella IgG | HIV DUO Antigen & Antib (VIDAS 4th gen) VZV IgG Hepatitis B core total Hep B surface antigen Anti-HCV Rubella IgG | Other |
| HepA IgM | HepA IgM | Other |
| HepAtAb | HepAtAb | Other |
| HepBeAb | HepBeAb | Other |
| HepBeAg | HepBeAg | Other |
| HepBsAb | HepBsAb | Other |
| HepC Ab | HepC Ab | Other |
| IMMY sōna Aspergillus | IMMY sōna Aspergillus | Other |
| Investigation of crystal microscopy for the diagnosis of gout | Investigation of crystal microscopy for the diagnosis of gout | Other |
| Isolation of bacterial and fungal species of clinical significance | Isolation of bacterial and fungal species of clinical significance | Other |
| Liaison QuantiFERON TB Gold Plus assay | Liaison QuantiFERON TB Gold Plus assay | Other |
| Norovirus (GI and GII) | Norovirus (GI and GII) | Other |
| Qualitative detection of the PVL-gene | Qualitative detection of the PVL-gene | Other |
| Quantitative determination of β-glucan | Quantitative determination of β-glucan | Other |
| Serological examination activities for the purposes of clinical diagnosis Mycoplasma pneumoniae IgM | Serological examination activities for the purposes of clinical diagnosis Mycoplasma pneumoniae IgM | Other |
| Shigella spp./Enteroinvasive E. coli | Shigella spp./Enteroinvasive E. coli | Other |
| VTEC and Rotavirus A | VTEC and Rotavirus A | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.